ARKANSAS, USA — UAMS announced Wednesday that it is the first provider in Arkansas to use NanoKnife technology, a new form of focal therapy for localized prostate cancer.
Focal therapy is a minimally invasive outpatient procedure that uses different forms of energy to target only the area of the prostate where cancerous cells are located and destroy them while sparing damage to surrounding tissue. It carries a lower risk of side effects than radiation and surgery, which are the other treatments for prostate cancer.
The specific NanoKnife form of focal therapy uses irreversible electroporation (IRE), which consists of short, high-voltage electrical pulses, to isolate the tumor without overtreating the entire prostate gland…